sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
20-Nov-2014 18:13
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 751-775 out of 932.

<< < 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>

Public Release: 16-Apr-2013
mBio
TGen-led study discovers dramatic changes in bacteria following male circumcision
Male circumcision reduces the abundance of bacteria living on the penis and might help explain why circumcision offers men some protection against HIV, according to a study led by the Translational Genomics Research Institute.
National Institutes of Health, Northern Arizona University

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 16-Apr-2013
mBio
Haiti cholera mutations could lead to more severe disease
The cholera strain that transferred to Haiti in 2010 has multiple toxin gene mutations that may account for the severity of disease and is evolving to be more like an 1800s version of cholera.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University

Public Release: 15-Apr-2013
Proceedings of the National Academy of Sciences
La Jolla Institute's surprising finding could alter the face of dengue vaccine development
As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design. The finding runs counter to current scientific understanding of the key cells that need to be induced to develop a successful dengue vaccine.

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology

Public Release: 11-Apr-2013
Proceedings of the National Academy of Sciences
Discovery points to new approach to fight dengue virus
Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive mosquito-borne pathogen.
National Institutes of Health

Contact: Emil Venere
venere@purdue.edu
765-494-4709
Purdue University

Public Release: 11-Apr-2013
Polio eradication is achievable by 2018 and urgent, declare 400+ global scientists
Hundreds of scientists and technical experts from 80 countries historically launched the Scientific Declaration on Polio Eradication on 11 Apr. 2013. The world has never been closer to a world free from polio. At this unique moment, scientists have come together to stress the achievability of polio eradication and endorse the Eradication and Endgame Strategic Plan, a new strategy by the Global Polio Eradication Initiative to reach and sustain eradication.

Contact: Dan Pawson
dpawson@globalhealthstrategies.com
718-873-3169
Global Health Strategies

Public Release: 11-Apr-2013
Leading organizations back Global Action Plan
More than 100 nongovernmental organizations and civil society organizations, joined by dozens of leading experts, expressed their support today for the World Health Organization and UNICEF's first-ever global plan to simultaneously tackle pneumonia and diarrhoea -- diseases that take the lives of almost two million children each year -- and urged governments and their partners to make the plan a reality.

Contact: Guillermo Meneses
Guillermo.Meneses@gmmb.com
202-445-1570
PATH

Public Release: 11-Apr-2013
Cell
Cell-destroyer that fights and promotes TB reveals what's behind its split identity
TB can be a disease not only of failed immunity but also of excessive immune response. Tumor necrosis factor -- normally an infection-fighting substance produced by the body -- can actually heighten susceptibility to tuberculosis if its levels are too high.
National Institutes of Health, Northwest Regional Center of Excellence for Biodefense

Contact: Leila Gray
leilag@uw.edu
206-685-0381
University of Washington

Public Release: 11-Apr-2013
Nature
Launch of semi-synthetic artemisinin a milestone for malaria, synthetic biology
The best therapy today for malaria is a drug combination that includes a derivative of artemisinin, now solely available from plants grown in Asia and Africa. On Apr. 11, Sanofi will launch the first semi-synthetic version of artemisinin, derived from yeast developed by biotech company Amyris from discoveries in the laboratory of Jay Keasling at UC Berkeley.
Gates Foundation

Contact: Robert Sanders
rsanders@berkeley.edu
510-643-6998
University of California - Berkeley

Public Release: 10-Apr-2013
Journal of Development and Behavioral Pediatrics
Training gives kids of AIDS patients a leg up
A simple in-home training program for caregivers can give children of AIDS patients a better shot at prosperity by improving their early-childhood development, according to a study led by a Michigan State University researcher.
National Institutes of Health

Contact: Andy McGlashen
andy.mcglashen@cabs.msu.edu
517-420-1908
Michigan State University

Public Release: 10-Apr-2013
BMJ
In an economic crash, public health improves
The economic crash in Cuba following the fall of the Soviet Union has provided researchers with a unique natural experiment on obesity, diabetes and heart disease, according to a study in the British Medical Journal.

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System

Public Release: 10-Apr-2013
Bulletin of the World Health Organization
Researchers develop tool to assist areas of infectious disease outbreaks
Researchers have developed a simple new tool to help governments worldwide decide whether to screen airplane passengers leaving or arriving from areas of infectious disease outbreaks.
Canadian Institutes of Health Research

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital

Public Release: 10-Apr-2013
DNDi Latin America pledges 2013 Carlos Slim Health Award to chagas disease
The Drugs for Neglected Diseases initiative Latin America today announced that it will pledge the US $100,000 Carlos Slim Health Award to Chagas disease, the leading parasitic killer of the Americas.

Contact: Betina Moura
bmoura@dndi.org
55-218-122-4166
Drugs for Neglected Diseases Initiative

Public Release: 10-Apr-2013
Proceedings of the Royal Society B
Fighting disease from within the mosquito: New techniques to help halt the spread of disease
Scientists have revealed a new technique to introduce disease-blocking bacteria into mosquitoes, with promising results that may halt the spread of diseases such as dengue, yellow fever and potentially malaria.

Contact: Nerissa Hannink
nhannink@unimelb.edu.au
61-430-588-055
University of Melbourne

Public Release: 9-Apr-2013
Circulation
'Diseases of affluence' spreading to poorer countries
High blood pressure and obesity are no longer confined to wealthy countries, a new study has found.
Medical Research Council, NIH/National Institute for Health Research Imperial Biomedical Research Centres

Contact: Sam Wong
sam.wong@imperial.ac.uk
44-207-594-2198
Imperial College London

Public Release: 9-Apr-2013
World Vaccine Congress
IDRI and Medicago to present data at the World Vaccine Congress
IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, will present positive interim Phase I clinical results for their H5N1 Avian Influenza VLP vaccine candidate.
DARPA

Contact: Lee Schoentrup
lee.schoentrup@idri.org
206-518-6290
Infectious Disease Research Institute

Public Release: 9-Apr-2013
PLOS Medicine
Treatment leads to near-normal life expectancy for people with HIV in South Africa
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80 percent of that of the general population provided that they start treatment before their CD4 count drops below 200 (cells per microliter), according to a study by South African researchers published in this week's PLOS Medicine.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Fiona Godwin
fgodwin@plos.org
01-223-442-834
PLOS

Public Release: 8-Apr-2013
DNDi welcomes the Global Health Innovative Technology Fund (GHIT)
The Drugs for Neglected Diseases initiative (DNDi), based in Geneva, Switzerland, and DNDi Japan, based in Tokyo, welcome the launch of the Global Health Innovative Technology Fund, an initiative supported by the Japanese government, several Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation.

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 8-Apr-2013
Journal of Traumatic Stress
Transcendental Meditation significantly reduces posttraumatic stress in African refugees
The Transcendental Meditation technique has been shown to lower posttraumatic stress in veterans of Vietnam and Iraq/Afghanistan wars. This is the first study to look at PTS in African war refugees. The Post-Traumatic Stress Disorder Checklist scores in the TM group went from high PTS symptoms at baseline to a non-symptomatic level after 30-days TM practice, and remained low at 135-days, while scores in the control group trended upward from baseline to the two posttests.
David Lynch Foundation

Contact: Ken Chawkin
kchawkin@mum.edu
641-470-1314
Maharishi University of Management

Public Release: 7-Apr-2013
Regional World Health Summit, Asia, Singapore
Nature
Global burden of dengue is triple current estimates
The global burden of dengue infection is more than triple current estimates from the World Health Organization, according to a multinational study published today and part-funded by the Wellcome Trust.
Wellcome Trust

Contact: Jen Middleton
j.middleton@wellcome.ac.uk
44-207-611-7262
Wellcome Trust

Public Release: 5-Apr-2013
Diabetologia
Treatments, not prevention, dominate diabetes research
Research for diabetes is far more focused on drug therapies than preventive measures, and tends to exclude children and older people who have much to gain from better disease management, according to a Duke Medicine study.
US Food and Drug Administration

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 5-Apr-2013
PLOS ONE
Highly lethal Ebola virus has diagnostic Achilles' heel for biothreat detection, scientists say
By screening a library of a billion llama antibodies on live Ebola viruses in the Texas Biomedical Research Institute's highest biocontainment laboratory, scientists in San Antonio have identified a potential weakness in the make-up of these deadly agents that can immediately yield a sensitive test.
National Institutes of Health, Defense Threat Reduction Agency, Texas Biomed

Contact: Joseph Carey
jcarey@txbiomed.org
210-258-9437
Texas Biomedical Research Institute

Public Release: 3-Apr-2013
Nature
Researchers find potential map to more effective HIV vaccine
By tracking the very earliest days of one person's robust immune response to HIV, researchers have charted a new route for developing a long-sought vaccine that could boost the body's ability to neutralize the virus.
NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 1-Apr-2013
Genetics
Mosquito genetic complexity may take a bite out of efforts to control malaria
A team of scientists from West Africa, the United States and the United Kingdom found that the mosquito, Anopheles gambiae, which was thought to be splitting into two completely new species, may actually have a more complex range of forms due to frequent inter-mating. The resulting hybrids, in sub-Saharan western Africa, may have implications for insecticide resistance and malaria parasite infectivity.

Contact: Phyllis Edelman
pedelman@genetics-gsa.org
301-634-7302
Genetics Society of America

Public Release: 27-Mar-2013
Journal of Human Resources
Sex discrimination begins in the womb
Women in India are more likely to get prenatal care when pregnant with boys, according to groundbreaking research that has implications for girls' health and survival.

Contact: Andy Henion
henion@msu.edu
517-355-3294
Michigan State University

Public Release: 25-Mar-2013
International Journal of Gynecology & Obstetrics
Ghanaian pregnant women who sleep on back at increased risk of stillbirth
Pregnant women in Ghana who slept on their back (supine sleep) were at an increased risk of stillbirth compared to women who did not sleep on their back, according to new research led by a University of Michigan researcher.

Contact: Mary Masson
mfmasson@umich.edu
734-764-2220
University of Michigan Health System

Showing releases 751-775 out of 932.

<< < 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>